Try our Advanced Search for more refined results

Genentech, MedImmune Settle Synagis Patent Spat

By Jocelyn Allison (June 12, 2008, 12:00 AM EDT) -- Biotechnology giant Genentech Inc. has dropped its patent dispute over MedImmune Inc.'s blockbuster drug Synagis, but its battle to uphold the validity of the patent at the center of the litigation continues....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!